Multiple Myeloma Rx Gets New Formulation
The US Food and Drug Administration (FDA) has approved a new formulation of a drug that treats a type of blood cancer.
Boosting Leukemia Survival
Umbilical cord blood transplants may lead to high survival in patients with leukemia who are at high risk for relapse post-transplant, a new study found.
New Treatment Offers Hope for Multiple Myeloma
Multiple myeloma is a hard cancer to cure. But there may be some good news on that front.
In Early Tests, Blood, Bone Marrow Rx Sparked Hope
Early testing of a medication for blood cancers and bone marrow disorders yielded promising results. Now, researchers are looking to the future.
Great Leaps in Leukemia Treatment
Cancer research has led to longer lives and better quality of life for millions of people. This year, the transformation of leukemia treatment has been singled out as the “Advance of the Year.”
FDA Approves New Cancer Medication
The US Food and Drug Administration (FDA) approved Zydelig (idelalisib) today to treat patients with three types of blood cancers.
Mega-Dose of Measles Vaccine Killed Cancer
Multiple myeloma is a cancer that develops in the bone marrow and is considered by many to be incurable. An engineered measles virus, however, may change that.
Why Childhood Cancer Survival Rates Have Increased
With increasing survival rates for many types of childhood cancers, some of these cancers are approaching cures. Several key events have made this possible.
Hodgkin Lymphoma Treatment May Boost Breast Cancer Risks
The vast majority of children who develop Hodgkin lymphoma beat the blood cancer after treatment, which includes powerful radiation. A new study looked at how that therapy affected young patients later in life.
Non-Hodgkin Lymphoma Rx Reduced Tumors
A new type of medication that disables lymphoma tumor cells has shown considerable success for patients who were not responding to other treatments.